Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer.

ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer. PLoS One. 2014; 9(7):e102388.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.